Heartland Virus Disease in the United States, 2018–2024
The American Journal of Tropical Medicine and Hygiene · 10.11.2026
DOI: 10.4269/ajtmh.26-0246 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, erschienen am 10.11.2026. Verfasst von Hannah Padda und 22 weiteren Autor:innen. Beteiligte Einrichtung: Arboviral Diseases Branch, US Centers for Disease Control and Prevention, Fort Collins, Colorado, USA. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Heartland virus (HRTV), a tick-borne virus, was first discovered as a cause of human disease in Missouri in 2011. Heartland virus disease presents similarly to other tick-borne infectious diseases, with acute febrile illness accompanied by thrombocytopenia, leukopenia, and elevated liver enzymes. In 2018, diagnostic testing for HTRV disease by reverse transcriptase polymerase chain reaction, IgM microsphere immunosorbent assay, and plaque reduction neutralization test became routinely available at the CDC. We describe the demographics and geographic distribution of patients tested for evidence of HRTV disease, and we note the clinical outcomes of patients with HRTV disease identified during 2018–2024. Of 279 patients tested, we identified 38 patients with laboratory evidence of HRTV disease (median of 5 patients per year). Patients resided in 13 states located in the eastern, southeastern, and central United States. All patients were ages 50 years old and older, 29 (76%) were male, and most ( n = 36; 95%) had illness onset during April to September. Among patients with HRTV disease, 92% were hospitalized, and 13% died. Compared with patients with no evidence of HRTV disease, HRTV disease patients were older (median age = 68 versus 51 years old, P
Autor:innen und Institutionen
- Arboviral Diseases Branch, US Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
- Missouri Department of Health and Senior Services, Jefferson City, Missouri, USA.
- Division of Epidemiology and Health Planning, Kentucky Department for Public Health, Frankfort, Kentucky, USA.
- Arkansas Department of Health, Little Rock, Arkansas, USA.
- Division of Infectious Diseases, Illinois Department of Public Health, Springfield, Illinois, USA.
- Kansas Department of Health and Environment, Topeka, Kansas, USA.
Zitieren
APA
Padda, H., Baker, M., Beddo, M., Smith, M., Hedges, S., Popovitch, J., Lindemann, S., Petro, E., Moncayo, A. C., Fisher, T., Coughlin, J., Richardson, K., White, J., Mason, K., Schafer, A., Broyhill, J., Fitzpatrick, K. A., Laven, J., Panella, A., …, & Staples, J. E. (2026). Heartland Virus Disease in the United States, 2018–2024. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.26-0246
Vancouver
Padda H, Baker M, Beddo M, Smith M, Hedges S, Popovitch J, et al. Heartland Virus Disease in the United States, 2018–2024. The American Journal of Tropical Medicine and Hygiene. 2026. doi:10.4269/ajtmh.26-0246
BibTeX
@article{Padda2026,
author = {Padda, Hannah and Baker, Molly and Beddo, Monica and Smith, Morgan and Hedges, Stephen and Popovitch, Jonathan and Lindemann, Stephanie and Petro, Erin and Moncayo, Abelardo C and Fisher, Teresa and Coughlin, Julie and Richardson, Kira and White, Jennifer and Mason, Krystal and Schafer, Ashley and Broyhill, James and Fitzpatrick, Kelly A and Laven, Janeen and Panella, Amanda and Velez, Jason and Lehman, Jennifer and Gould, Carolyn V and Staples, J Erin},
title = {Heartland Virus Disease in the United States, 2018–2024},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2026},
doi = {10.4269/ajtmh.26-0246}
}
EUVIMED